Ignite Creation Date:
2024-05-05 @ 9:10 PM
Last Modification Date:
2024-10-26 @ 10:00 AM
Study NCT ID:
NCT00822809
Status:
COMPLETED
Last Update Posted:
2012-10-03
First Post:
2008-12-23
Brief Title:
CASIMAS Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Organization Data
Organization:
Neovii Biotech
Class:
INDUSTRY
Study ID:
IP-CAT-AC-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neovii Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None